TGFB1 and neoplasm: Hostile tumor microenvironment contributes to decrease the optimum efficacy of CAR T cells via multiple mechanisms such as the activity of fibroblasts and extracellular matrix, soluble factors/cytokines (such as TGFβ), and immunosuppressive immune cells including T-regs and myeloid-derived suppressor cells (MDSCs) (45).